Synaptic interactions between perifornical lateral hypothalamic area, locus coeruleus nucleus and the oral pontine reticular nucleus are implicated in the stage succession during sleep-wakefulness cycle by Tortorella, Silvia et al.
ORIGINAL RESEARCH ARTICLE
published: 19 November 2013
doi: 10.3389/fnins.2013.00216
Synaptic interactions between perifornical lateral
hypothalamic area, locus coeruleus nucleus and the oral
pontine reticular nucleus are implicated in the stage
succession during sleep-wakefulness cycle
Silvia Tortorella , Margarita L. Rodrigo-Angulo , Angel Núñez* and Miguel Garzón
Departamento de Anatomía, Histología y Neurociencia, Facultad de Medicina, Research Institute, Universidad Autonoma de Madrid, La Paz University
Hospital (IDIPAZ), Madrid, Spain
Edited by:
Michel A. Steiner, Actelion
Pharmaceuticals Ltd., Switzerland
Reviewed by:
Rodrigo Espana, Drexel University
College of Medicine, USA
Hiroshi Katsuki, Kumamoto
University Graduate School of
Pharmaceutical Sciences, Japan
*Correspondence:
Angel Nuñez, Departamento de
Anatomía, Histología y
Neurociencia, Facultad de Medicina,
Research Institute, Universidad
Autonoma de Madrid, La Paz
University Hospital (IDIPAZ),
c/ Arzobispo Morcillo 4, 28029
Madrid, Spain
e-mail: angel.nunez@uam.es
The perifornical area in the posterior lateral hypothalamus (PeFLH) has been implicated
in several physiological functions including the sleep-wakefulness regulation. The PeFLH
area contains several cell types including those expressing orexins (Orx; also known
as hypocretins), mainly located in the PeF nucleus. The aim of the present study was
to elucidate the synaptic interactions between Orx neurons located in the PeFLH area
and different brainstem neurons involved in the generation of wakefulness and sleep
stages such as the locus coeruleus (LC) nucleus (contributing to wakefulness) and the
oral pontine reticular nucleus (PnO) nucleus (contributing to REM sleep). Anatomical
data demonstrated the existence of a neuronal network involving the PeFLH area,
LC, and the PnO nuclei that would control the sleep-wake cycle. Electrophysiological
experiments indicated that PeFLH area had an excitatory effect on LC neurons. PeFLH
stimulation increased the firing rate of LC neurons and induced an activation of the
EEG. The excitatory effect evoked by PeFLH stimulation in LC neurons was blocked by
the injection of the Orx-1 receptor antagonist SB-334867 into the LC. Similar electrical
stimulation of the PeFLH area evoked an inhibition of PnO neurons by activation of
GABAergic receptors because the effect was blocked by bicuculline application into the
PnO. Our data also revealed that the LC and PnO nuclei exerted a feedback control on
neuronal activity of PeFLH area. Electrical stimulation of LC facilitated firing activity of
PeFLH neurons by activation of catecholaminergic receptors whereas PnO stimulation
inhibited PeFLH neurons by activation of GABAergic receptors. In conclusion, Orx neurons
of the PeFLH area seem to be an important organizer of the wakefulness and sleep
stages in order to maintain a normal succession of stages during the sleep-wakefulness
cycle.
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INTRODUCTION
Sleep and wakefulness are two mutually exclusive states that cycle
with both ultradian and circadian periods. The brain mecha-
nisms underlying the organization of the sleep-wakefulness cycle
remain unclear. Many studies have identified several populations
of neurons whose activity correlates with distinct behavioral states
(Carter et al., 2012, 2013). The perifornical lateral hypothala-
mic area (PeFLH) has been implicated in several physiological
functions including sleep-wakefulness regulation (McGinty and
Szymusiak, 2003; Jones, 2008); this area contains a heteroge-
neous population of neuronal groups as reflected by both their
state-dependent discharge properties and their neurotransmitter
phenotypes. Among others, these cells express hypocretin/orexin
(Orx), melanin-concentrating hormone, γ-aminobutyric acid
(GABA) or glutamate (Vaughan et al., 1989; Bittencourt et al.,
1992; de Lecea et al., 1998; Sakurai et al., 1998; Abrahamson and
Moore, 2001; Rodrigo-Angulo et al., 2008). Orx neurons, mainly
located in the perifornical (PeF) nucleus, have been extensively
studied and implicated in the facilitation and/or maintenance
of arousal (Alam et al., 2002; Koyama et al., 2003; Siegel, 2004;
Sakurai, 2005; Takahashi et al., 2005; Sasaki et al., 2011); they are
maximally active during active wakefulness and virtually cease fir-
ing during both slow wave sleep and rapid eye movement (REM)
sleep (Lee et al., 2005a; Mileykovskiy et al., 2005).
Hypothalamic Orx projections make asymmetrical synaptic
contacts with their target neurons in numerous brain areas impli-
cated in the control of sleep-wakefulness cycle (Peyron et al., 1998;
Horvath et al., 1999). Excitatory Orx effects have been demon-
strated in neurons of arousal-related structures including the
locus coeruleus (LC) nucleus (Horvath et al., 1999; Eggermann
et al., 2001; Marcus et al., 2001; Burlet et al., 2002; Yamanaka
et al., 2002; España et al., 2005; Cid-Pellitero and Garzon, 2011)
where Orx promotes wakefulness (Bourgin et al., 2000; España
et al., 2001; Thakkar et al., 2001; Xi et al., 2001). This effect may
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be due to an excitatory effect of Orx on LC neurons, as has been
demonstrated in vitro (Hagan et al., 1999; Horvath et al., 1999;
Ivanov and Aston-Jones, 2000; Soffin et al., 2002), suggesting that
the effect of Orx on LC neurons may facilitate the arousal state.
Orx axon terminals and Orx receptors have also been iden-
tified in cholinoceptive areas of the pontine reticular formation
involved in REM sleep generation (Greco and Shiromani, 2001;
Marcus et al., 2001; Willie et al., 2003). Cholinoceptive neurons
located in the ventral part of the oral pontine reticular nucleus
(PnO) are involved in the generation and maintenance of REM
sleep in rats (Horner and Kubin, 1999; Kohlmeier et al., 2002;
Nuñez et al., 2002) and cats (Reinoso-Suárez et al., 1994, 1999,
2001; Garzón et al., 1998). Orx receptor subtypes are expressed
in PnO neurons (Greco and Shiromani, 2001; Willie et al., 2003)
and activation of such receptors enhances acetyl-choline release in
the rat pons (Bernard et al., 2003, 2006). However, iontophoretic
application of Orx in the PnO nucleus induced an inhibition
of neuronal activity in anesthetized rats (Nuñez et al., 2006a);
this effect was blocked by a previous iontophoretic application of
bicuculline, indicating that inhibitory action of Orx involves the
activation of GABAA receptors.
The above mentioned results suggest that Orx neurons may
play a crucial role in the organization of the sleep-wakefulness
cycle and consequently, damage to Orx neurons could disrupt
the normal succession of sleep-wake stages, as occurs in human
narcolepsy and in animal models of this sleep disorder (Peyron
et al., 2000; Thannickal et al., 2000). Narcolepsy is a neurological
disorder characterized by severe daytime somnolence with a con-
stellation of unusual symptoms that are best understood as intru-
sions of REM sleep phenomena into wakefulness (Guilleminault
and Fromherz, 2005). In agreement with the hypothesis that
Orx neurons play a role in narcolepsy these patients also have
reduced cerebrospinal fluid levels of Orx (Nishino et al., 2000).
Animal models exhibiting symptoms of narcolepsy show loss of
Orx neurons or a decrease in Orx levels (Chemelli et al., 1999;
Gerashchenko et al., 2001; Hara et al., 2001; Beuckmann et al.,
2004). Canines with narcolepsy carry a mutation in the Orx-2
receptor (Lin et al., 1999) andmice with a deletion of this receptor
(Willie et al., 2003) also show symptoms of narcolepsy.
The aim of the present study was to examine the synaptic
interaction between Orx neurons located in the PeFLH area and
different neuronal generators in the brainstem. We hypothesized
that cross-talk among LC nucleus (contributing to wakefulness),
PnO nucleus (contributing to REM sleep) and PeFLH area would
orchestrate the sleep-wakefulness cycle. Anatomical and elec-
trophysiological studies were undertaken to demonstrate this
coordination of the sleep-wakefulness cycle.
MATERIALS AND METHODS
Procedures were approved by the Ethics Board of the Universidad
Autonoma de Madrid in accordance with the European
Communities Council guidelines (2012/63/UE) on the ethi-
cal use of animals with every effort being made to mini-
mize the suffering and number of animals employed. Fifty-five
urethane-anesthetized (1.6 g/kg i.p.)Wistar rats (from Iffa-Credo,
L’Arbresle, France) weighing 250–300 g were used for the physio-
logical experiments. Animals were placed in a stereotaxic device
with controlled body temperature (37◦C). EEG activity was
recorded through a macroelectrode stereotaxically placed into the
frontal cortex [at 2mm rostral to the Bregma and 2mm from
the midline (Paxinos and Watson, 2007)]. The EEG was filtered
between 0.3 and 30Hz, and amplified. Supplemental doses of the
anesthetic were given when a decrease in the amplitude of the EEG
delta waves was observed.
UNIT RECORDING AND DRUG APPLICATION
Single-unit recordings were obtained with tungsten micro-
electrodes (2M) or glass micropipettes (World Precision
Instruments, Sarasota, USA) filled with 2% neurobiotin in 0.5M
NaCl (Sigma) to locate the recording site. Three-barrel glass
micropipettes were also used for unit recording and simultane-
ous application of pharmacological agents by microiontophoresis
(see below).
Recording electrodes were placed at the LC nucleus (coor-
dinates from Bregma: A, −9.3; L, 1.5 and depth, 7.0mm), the
PnO nucleus (coordinates from Bregma: A, −8.0; L, 1.0 and
depth, 8.0mm) or at the PeFLH area (coordinates from Bregma:
A, −2.1; L, 1.0 and depth, 8.0mm) by means of micromanipula-
tors. Extracellular recordings were filtered (0.3–3 kHz), amplified
(P15; GRASS Technology, Warwick, USA) and fed into a PC
computer for off-line analysis by a Cambridge Electronic Design
(CED; Cambridge, UK) 1401 interface at a sampling frequency of
10 kHz for the unit recordings, together with the EEG (sampling
frequency of 200Hz). Spike 2 software (CED) was used.
When barrel micropipettes were used, one of the glass capil-
laries was filled with a solution of NaCl (0.5M) in order to record
unit activity. A second micropipette was filled with bicuculline-
methiodide (10mM in 0.9% NaCl, pH 3.0, Sigma, St Louis, MO,
USA). The remaining micropipette was filled with 0.5M NaCl to
balance the retention and ejection currents. Each barrel of the
three-barreled pipette was connected via a silver wire to a chan-
nel on a microiontophoresis current generator (World Precision
Instruments) that controlled retention and ejection currents for
the drug-filled micropipette. Bicuculline was ejected with a pos-
itive current using a single 30-s pulse of 50 nA and negative
retaining currents of 10–20 nA were used to delay drug leakage
from the micropipette.
Bipolar stimulating electrodes (120μm diameter blunt stain-
less steel wire) were placed at the ipsilateral PeFLH area, LC
nucleus or in the PnO nucleus (same coordinates as described
above). Electrical stimulation was performed using single rect-
angular pulses (0.1–0.3ms, 50–100μA) at 0.5Hz or pulse trains
of 500-ms duration at a frequency of 50Hz, delivered through a
GRASS S88 stimulator.
DRUGS
The hypocretin-1 receptor antagonist SB-334867 (100μM;
100 nl) was applied through a 20G cannula connected to a
Hamilton syringe (flow rate: 50 nl/min). The dose was similar to
previous reports (Erami et al., 2012). Reserpine (methyl reser-
pate 3,4,5-trimethoxybenzoic acid ester, Sigma Chemical Co., St.
Louis, USA) was dissolved in 50μl of glacial acetic acid plus 0.9%
NaCl (saline). The control solution consisted of saline plus 50μl
of glacial acetic acid in saline. Reserpine doses (1.0 and 5.0mg/kg)
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were administered subcutaneously (s.c.) in a volume of 1.0ml/kg
of body weight. Unit recordings were performed 48 h after the
reserpine injection.
ELECTROPHYSIOLOGICAL DATA ANALYSIS
Analysis of the neocortical EEGs as well as the activity of each neu-
ron was performed off-line in a PC computer. Spike 2 software
was used to perform statistical calculations including summed
peristimulus time histograms (PSTH), which were calculated
using 2-ms bin widths and power spectra of the EEG. Statistical
analyses were calculated with Student’s two-tailed t tests for
unpaired or paired data as required. Differences were considered
statistically significant at a level of 95% (p < 0.05). All data are
indicated as mean ± SEM.
ANATOMICAL STUDIES
At the end of the electrophysiological experiments animals were
injected i.p. with an overdose of pentobarbital and perfused tran-
scardially with 4% paraformaldehyde in phosphate buffer pH 7.4.
Brains were frozen, sectioned at 50μmand collected in two series.
In order to confirm the location of the recording electrodes, sec-
tions from the first series were processed to reveal the neurobiotin
stained neurons: after rinsing in Tris saline buffer (TS) 0.1M at
pH 7.6, sections were incubated in a 1:150 Elite ABC kit (Vector)
dilution in TS and 0.25% triton X-100 for 3 h to be developed
with 0.05% 3-3′ DAB and 0.003% H2O2. Sections of the second
series were processed for Nissl staining in order to corroborate the
location of the stimulating electrodes.
For the anatomical connection tracing studies, retrograde
Cholera Toxin-Alexia 594 (CT-A) and 1.5% Fluoro-Gold (FG)
and anterograde FluoroRuby (FR) fluorescents tracers were
injected in 16 adult rats of both sexes weighing 250–280 g. Under
general anesthesia (a mixture of 50% ketamine, 40% atropine,
and 10% valium i.p. 1ml/250 g) animals were placed in the stereo-
taxic frame, and a craniotomy was made. Fluorescent injections
were performed in PnO and LC nuclei, both in the same hemi-
spheric side by means of a 1μl Hamilton syringe (flow rate:
40 nl/min). In order to avoid contamination and tracer overlap-
ping, injections in PnO nucleus were made from the contralateral
side in an angle of 45◦ at coordinates from Bregma: A, −8.4; L,
1.5, and depth, 8.5, according to the (Paxinos and Watson, 2007);
300 nl of CT-A (10 animals), 40 nl of FG (3 animals), and 450 nl
of FR (3 animals) were delivered in a single pulse. Injections in
LC nucleus were performed with a vertical approach using a 1μl
Hamilton syringe stereotaxicaly aimed at the coordinates from
Bregma: A, −9.6; L, 1.3; and depth 6.8; 50 nl of FG (12 animals),
50 nl of FR (2 animals), and 300 nl of CT-A (2 animals) were
delivered. Animals were allowed to survive for 7 days before tran-
scardial perfusion with 4% paraformaldehyde in 0.1M phosphate
buffer at pH 7.3 followed by increasing concentrations of sucrose
solutions in the same buffer. Once removed, brains were stored
in 30% sucrose solution during 5 days for cryopreservation and
afterwards sectioned at 40μm on a cryostat; sections were col-
lected in three consecutive series devoted to fluorescence and
Nissl staining. The third series was processed for Orx immunola-
beling using the avidin-biotin-peroxidase method; sections were
incubated with 1:1000 goat anti-Orx antiserum (Santa Cruz) in
a solution containing 5% bovine serum albumin and 30% nor-
mal rabbit serum in Tris buffer 0.1M at pH 7.6 for 48 h. After
this, sections were incubated in 1:400 biotinylated rabbit anti-goat
antibody solution (Chemicon) for 2 h and in 1:150 avidin-biotin-
peroxidase reagent Elite ABC kit (Vector) for 1.5 h. The Orx
immunoperoxidase was visualized by incubation in 0.05% 3-3′
DAB and 0.003% H2O2. Sections were studied under fluorescent
or bright field illumination using a Zeiss Axioskop microscope.
RESULTS
ANATOMICAL RESULTS
To determine the projections from the PeF area, two retrograde
tracers CT-A and FG were injected into the LC and PnO nuclei,
respectively (Figures 1A,B). Also, the anterograde FR fluores-
cent tracer was used. Numerous retrograde labeled neurons were
observed in several hypothalamic structures after PnO tracer
injections, as we have already reported (España et al., 2005;
Nuñez et al., 2006a; Figure 1C). The injections of the anterograde
tracer in PnO nucleus labeled fibers and terminals only in the
lateral sector of PeFLH area (Figure 1E). Neurons labeled after
retrograde tracer injections in LC nucleus were located in the ven-
tral sector of PeFLH area and intermingled with the fibers and
terminals that could be observed after anterograde tracer injec-
tions in LC nucleus (Figures 1D,F). In all cases, the presence of
double-labeled neurons was very low (<0.5% of labeled neurons).
A schematic drawing of the hypothalamic area depicting dif-
ferential distribution of retrograde labeled neurons and antero-
grade labeled fibers after PnO and LC tracer injections is shown in
Figure 2A. As has been previously reported (Nuñez et al., 2006a)
Orx immunoreactive neurons were clustered to the PeF nucleus
(Figure 2B). In the PeF nucleus we found double-labeled neurons
projecting to PnO (data not shown) or to LC nucleus (Figure 2C)
that were also stained for Orx.
PeF ACTIVATION OF LC
The LC neurons displayed a non-rhythmic discharge pattern with
a mean spontaneous frequency of 3.4 ± 1.0 spikes/s (n = 40).
The recording site was established by iontophoretic injection of
neurobiotin through the recording micropipette (Figure 3, inset).
Trains of electrical stimulus delivered in the PeFLH area
(50Hz; 50μA; 500ms of duration) increased the mean firing rate
of LC neurons from 3.4 ± 1.0 to 9.8 ± 1.7 spikes/s, measured 10 s
after the stimulation train (p < 0.001; Figures 3A,C). The exci-
tatory effect was observed in 64% of LC neurons (32 out of 50
cells), and could last up to 30 s. The EEG pattern changed from
continuous slow waves evoked by the anesthetic to a faster activity
evoked by PeFLH stimulation (Figure 3A). In spontaneous con-
ditions the percentage of delta waves (1–4Hz) in the EEG was
98.6± 1.8% and the percentage of faster (>4Hz) waves was 1.4±
0.9%. During the period of 10 s after the PeFLH stimulation train
the proportion of delta waves decreased to 67.3 ± 3.4% and the
percentage of >4Hz waves increased to 32.7 ± 4.6% (p < 0.001),
indicating that the PeFLH stimulation induced an activation of
the EEG.
The excitatory effect evoked by PeFLH stimulation in LC neu-
rons was blocked by the injection of the Orx-1 receptor antagonist
SB-334867 into the LC nucleus. The SB-334867 was applied by
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FIGURE 1 | Anatomical projections between PeFLH area and LC or PnO
nuclei. (A) Microphotograph showing a representative case of FR injection
aimed at PnO from the contralateral side. Dash line indicates midline; solid
line indicates the IV ventricle contour. (B) Microphotograph of a FG injection
aimed at LC. (C,D) Microphotographs showing labeled neurons in the PeF
area after FG injection in PnO nucleus (C) and LC nucleus (D). (E,F)
Microphotographs of two cases showing fiber terminals after FR injections
in PnO nucleus (E) and LC nucleus (F). f: fornix. Calibration bars in (A) and
(B), 500μm. Calibration bars in (C–F), 150μm.
means of a Hamilton syringe (100μM; 100 nl) and the effect was
tested 15min. after application when the drug concentration was
stabilized. Trains of electrical stimulus delivered in the PeFLH
area (50Hz; 50μA; 500ms of duration) increased the mean firing
rate (calculated during 10 s before and 10 s after the stimulation
train) of LC neurons from 2.8± 0.8 to 6.3± 1.2 spikes/s, (n = 12;
p < 0.001; Figures 3A,C). The excitatory responses evoked by
PeFLH stimulation train in LC neurons were blocked by the SB-
334867 (Figure 3B). Trains of electrical stimulus delivered in the
PeFLH area did not increase the mean firing rate of LC neu-
rons from 2.1 ± 0.9 to 2.8 ± 0.6 spikes/s (n = 12; p = 0.12;
Figures 3B,C).
PeF INHIBITION OF PnO ACTIVITY
Most PnO neurons (15 out of 18 neurons; 83%) decreased their
spontaneous firing rate from 1.2± 0.3Hz in control conditions to
0.2± 0.4Hz (p < 0.001) 10 s after application of a train of electri-
cal stimuli delivered in the PeFLH area (50Hz; 50μA; 500ms of
duration; Figure 4, upper trace). To determine if the inhibitory
response evoked by PeF stimulation was due to activation of
GABAergic receptors, bicuculline (a GABAA receptor antagonist;
10mM) was iontophoretically applied (n = 8). Bicuculline ejec-
tion increased the firing rate of PnO neurons to 4.9 ± 0.9Hz. In
FIGURE 2 | (A) Schematic drawing of the hypothalamic area in a coronal
section of rat brain at antero-posterior coordinates Bregma −3.36mm. It is
shown the distribution of neurons projecting to PnO (red dots) and LC (blue
dots) and the distribution of fiber terminals arising PnO and LC are
represented in green and purple small dots, respectively. (B)
Microphotograph of PeF showing neurons immunocytochemically stained
for anti-Orx. (C) Microphotograph showing adjacent section showed in (B)
where Orx neurons are pointed by black arrowheads, FG neurons
projecting to LC by white arrowheads and double labeled neurons by red
arrowheads. Calibration bar: 50μm. Abbreviations: 3V: 3rd ventricle; Arc:
arcuate hypothalamic nucleus; DMD: dorsomedial hypothalamic nucleus,
dorsal part; DMV: dorsomedial hypothalamic nucleus, ventral part; f: fornix;
mt: mammillothalamic tract; PeF: perifornical nucleus; PeFLH: perifornical
part of lateral hypothalamus area; PH: posterior hypothalamic nucleus;
PHD: posterior hypothalamic area, dorsal part; PLH: peduncular part of
lateral hypothalamus; Re: reuniens thalamic nucleus; Sth: subthalamic
nucleus; VMH: ventromedial hypothalamic nucleus; ZI: zona incerta.
the presence of bicuculline, successive PeFLH stimulation trains
did not change the firing rate of PnO neurons (Figure 4, lower
trace), indicating that the inhibitory effect of PeF stimulation was
due to activation of GABAergic receptors within the PnO nucleus,
in agreement with previous reports (Nuñez et al., 2006a).
PeF NEURONAL RESPONSES TO LC OR PnO STIMULATION
Unit recordings were performed in the PeFLH area (n = 39).
Neurons displayed a non-rhythmic discharge pattern with a mean
spontaneous frequency of 1.3± 0.3 spikes/s. PeFLH neurons were
identified by their stereotaxic coordinates after reconstruction of
the electrode track.
The PeFLH area is implicated in the control of the sleep-
wakefulness cycle, facilitating wakefulness (see Introduction). We
study the effect on PeFLH neuronal activity of electrical stimu-
lation of brainstem areas implicated in the generation of wake-
fulness (LC nucleus) or REM sleep (PnO nucleus). Trains of
electrical stimuli delivered in the LC nucleus (50Hz; 50–100μA;
500ms of duration) induced a 1–10 s increase in firing rate, in
most PeFLH neurons (21 out of 23 cells; 91%; Figure 5A). The
mean firing rate increased from 1.3 ± 0.3 spikes/s in spontaneous
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FIGURE 3 | PeFLH electrical stimulation excited LC neurons. (A) A train
of electrical stimuli (50Hz; 50μA; 500ms of duration) in the PeFLH area
(vertical arrow) evoked a long-lasting increase in LC neuronal activity and a
decrease of the EEG slow waves. The inset shows the recording area,
which was stained with neurobiotin. (B) This effect was blocked by the
injection of the Orx-1 receptor antagonist SB-334867 into the LC by means
of a Hamilton syringe (100μM; 100nl). (C) Plot of the mean neuronal
activity measured during a 10 s period before (black) and after (red) the
stimulus train in the PeFLH area. In control conditions (n = 12 cells) LC
neuronal activity increased, but the effect was blocked by the Orx-1
receptor antagonist. The asterisk indicates significant statistical differences
(∗∗p < 0.01).
conditions to 8.6 ± 1.4 spikes/s (n = 21; p < 0.001; Figure 5C).
The percentage of delta waves decreased during the same time
period from 96.5 ± 4.1 to 79.8 ± 2.9% (p < 0.001).
The alkaloid reserpine which depletes catecholamines from
nerve endings have been used. Reserpine administration
(1mg/kg, once daily for three consecutive days) reduced the
response of the PeFLH neurons to LC train stimulation. The
LC-evoked rise in the firing rate was reduced in the presence of
reserpine. Under reserpine activity rose from 1.3 ± 0.5 spikes/s
before the stimulation train to 2.8 ± 1.4 spikes/s after the stim-
ulation train; n = 8; p = 0.015; Figures 5B,C, indicating that
the LC-evoked excitation of PeF neurons was mediated by the
activation of catecholaminergic fibers.
To determine if there is a reciprocal connection between the
PeFLH area and PnO nucleus, electrical stimulation of the PnO
nucleus (0.5Hz; 50–100μA; 0.1–0.3ms of duration) was applied
during unit recordings of PeFLH neurons. Trains of electrical
stimulus delivered in the PnO nucleus (50Hz; 50–100μA; 500ms
of duration) induced a decrease of the firing rate in 14 out of
17 PeFLH neurons during 1–8 s (82%; Figure 6A). The remain-
ing neurons did not display significant changes in their firing
FIGURE 4 | PeFLH stimulation inhibited PnO neuronal activity. A train of
electrical stimuli (50Hz; 50μA; 500ms of duration) in the PeFLH area
(vertical arrow) evoked a long-lasting inhibition of PnO neurons (upper
trace). The inhibitory effect was blocked by the iontophoretic application of
the GABAA receptor antagonist bicuculline (10mM) into the PnO nucleus
(lower trace). Inset shows the stimulated PeFLH area in the Nissl stained
section (arrow).
rate. The mean firing rate of these neurons affected by PnO
train stimulation was 2.4 ± 0.5 spikes/s in spontaneous condi-
tions and this decreased to 1.4 ± 0.6 spikes/s during 2–5 s after
the stimulation train (n = 14; p = 0.009). PnO train stimula-
tion induced a short-lasting decrease of slow waves, probably by
activation of the basal forebrain through polysynaptic pathways
(Camacho Evangelista and Reinoso Suarez, 1964; Nuñez et al.,
2006b; Teruel-Marti et al., 2008).
The inhibition of PeFLH neuronal activity by PnO electrical
stimulation was blocked by iontophoretic application of bicu-
culline (10mM; n = 8; Figure 6B). Figure 5C shows the mean
firing rate in control conditions (n = 14) and under bicuculline
(10mM; n = 8). The spontaneous firing rate of PeFLH neurons
increased to 4.4 ± 1.2 spikes/s 5min after bicuculline application
and, in these conditions, PnO stimulation did not alter the fir-
ing rate of the neurons (5.0 ± 0.9 spikes/s), indicating that the
PnO-evoked inhibition of PeFLH neurons was dependent on the
GABAA receptor activation.
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FIGURE 5 | LC stimulation evoked a long–lasting excitation of PeFLH
neurons. (A) Train stimulation of the LC evoked an increase of PeF
neuronal activity for 3 s, with a simultaneous decrease in EEG slow waves.
The stimulation train is indicated by the open arrow. (B) LC-evoked
excitation was abolished in a reserpine-treated animal. (C) Plot of the mean
firing rate calculated for the 10 s period before (black) and after (red) LC
stimulation train in control animals (n = 21 cells) and in reserpine-treated
animals (n = 12 cells). The LC-evoked excitation of PeFLH neurons was
reduced after catecholaminergic depletion. The asterisk indicates significant
statistical differences (∗p < 0.05; ∗∗p < 0.01).
DISCUSSION
The present results demonstrate using anatomical and electro-
physiological methods the existence of a neuronal network involv-
ing the PeFLH area, LC, and PnO nuclei that would control the
sleep-wake cycle. The Orx PeF neurons favor EEG activation by
excitatory projections to the LC nucleus and simultaneously block
REM sleep generation by inhibition of PnO neurons through
GABAergic receptors. This study also reveals that the LC and
PnO nuclei exerted a feedback control on neuronal activity of
PeFLH area in order to maintain a normal succession of stages
during the sleep-wakefulness cycle. Top-down and bottom-up
regulatory mechanisms are engaged to control the succession of
sleep-wakefulness stages.
Both Orx-1 and Orx-2 receptors are expressed in the rodent
brainstem (Greco and Shiromani, 2001; Marcus et al., 2001).
Whereas the distribution of both receptors is quite similar in the
PnO nucleus (Greco and Shiromani, 2001; Cluderay et al., 2002;
Brischoux et al., 2008), LC nucleus shows a much more promi-
nent expression for Orx-1 receptor mRNA and protein (Trivedi
et al., 1998; Greco and Shiromani, 2001); Orx-2 receptors appear
to be virtually absent in noradrenergic neurons of the LC nucleus
(Brischoux et al., 2008). In agreement with these results, our
data show that application of the Orx-1 receptor antagonist SB-
334867 into the LC nucleus prevents the excitatory effect evoked
by PeFLH stimulation. The lesion of neurons expressing the Orx-
2 receptor in the lateral hypothalamus, by using the toxin Orx
2-saporin, have already revealed the implication of this receptor
in different narcoleptic signs (Gerashchenko et al., 2001, 2003).
FIGURE 6 | PnO electrical stimulation evoked a long-lasting inhibition
of PeFLH neurons. (A) Electrical train stimulation of the PnO nucleus
evoked a decrease in PeFLH neuronal activity for 5 s accompanied by a
slight decrease in EEG slow waves. The stimulation train is indicated with
open arrow. (B) The PnO-evoked inhibition was abolished by bicuculline
(10mM). (C) Plot of the mean firing rate calculated for the 10 s period
before (black) and after (red) the PnO stimulation train in control animals
(n = 14 cells) and 5min after bicuculline application (n = 8 cells). The
PnO-evoked inhibition was blocked by the GABAA receptor antagonist. The
asterisk indicates significant statistical differences (∗∗p < 0.01).
The additional utilization of selective Orx-2 antagonists in the
future could further help elucidate differential roles in regions
expressing both receptors, such as the PnO.
The PeFLH area has been implicated in the regulation of
behavioral arousal during wakefulness (Kilduff and Peyron, 2000;
Siegel, 2004; Szymusiak and McGinty, 2008). This area contains
Orx neurons mainly located in the PeF nucleus that are active
during wakefulness and silent or with a low activity during non-
REM and REM sleep (Alam et al., 2002; Koyama et al., 2003;
Lee et al., 2005a,b; Suntsova et al., 2007). In a previous study
we showed that Orx PeF neurons activate GABAergic receptors
to inhibit PnO neurons, controlling the onset of REM sleep and
thus, facilitating wakefulness (Nuñez et al., 2006a). In agreement
with this observation, Lu and collaborators demonstrated that
activation of PeF cells with bicuculline blocked the ability of pon-
tine carbachol injections to elicit REM sleep (Lu et al., 2007). In
the present study we show that there is a reciprocal connection
between PnO and PeF nuclei. Both pathways have an inhibitory
effect mediated by the activation of GABAA receptors because
effects were blocked by local application of the GABAA recep-
tor antagonist bicuculline. This experiment does not discard that
other pathways could activated by PeFLH stimulation through
other neurotransmitter actions. Consequently, when PeF neu-
rons are active they block the possibility of REM sleep generation
while PnO neurons activation during REM sleep inhibits PeF
neurons and prevents wakefulness. Moreover, GABAergic sleep-
active anterior hypothalamic neurons project to the PeF nucleus
and GABA release is increased in this region during slow wave
sleep (Nitz and Siegel, 1996; Saper et al., 2001, 2005; Uschakov
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et al., 2006). Thus, during slow wave and REM sleep PeF Orx
neurons are inhibited. The absence of Orx is associated with nar-
colepsy, a disorder manifested by an uncontrollable occurrence
of REM sleep (Chemelli et al., 1999; Lin et al., 1999; Thannickal
et al., 2000). In agreement with this, Orx knock-out mice show an
increase of slow wave and REM sleep during the darkness period,
whereas wakefulness is decreased (Chemelli et al., 1999).
In this study we further demonstrated in vivo that PeF neurons
facilitate wakefulness by direct excitation of LC neurons, which
contribute to arousal by excitation of thalamic and cortical neu-
rons (McCormick and Prince, 1988; McCormick, 1989; Aston-
Jones, 2005). Previous studies in brain slices or neuronal cultures
have demonstrated that Orx depolarizes LC neurons, increasing
their firing rate (Soffin et al., 2002; Murai and Akaike, 2005).
Also, the firing rates of LC neurons increased after microion-
tophoretic injection of Orx (Bourgin et al., 2000). LC neurons
recorded in the present study showed similar spontaneous fir-
ing rate in control conditions from anesthetized rats that previous
studies (Aston-Jones and Bloom, 1981; Bourgin et al., 2000) and
also are consistent with these previous studies in demonstrating
that Orx increases neuronal excitability in the LC nucleus through
the activation of the Orx-1 receptor, since excitability is dimin-
ished by the Orx-1 receptor antagonist SB-334867 (Gompf and
Aston-Jones, 2008). Orx innervation of LC neurons projecting to
the cortex has been reported recently (Cid-Pellitero and Garzon,
2011). This Orx innervation probably supplies excitatory inputs
to LC nucleus that are critical for cortical activation in transitions
from sleep to wakefulness and during EEG activation.
The activity of LC neurons is involved in maintenance of
wakefulness and EEG activation. These neurons are active during
wakefulness, decrease their firing rate during slow wave sleep and
are silent during REM sleep (Hobson andMcCarley, 1975; Aston-
Jones and Bloom, 1981). Unilateral lesions of the LC nucleus in
cats enhance REM sleep (Caballero and De Andres, 1986). Carter
and collaborators, using an optogenetic approach to stimulate
or inhibit LC neurons found that silencing LC neurons blocked
Orx-mediated sleep-to-wakefulness transitions while increasing
the excitability of LC neurons enhanced these transitions (Carter
et al., 2012, 2013).
Consequently with the above results, the LC nucleus plays a key
role in regulating the sleep-wakefulness cycle. To favor the wake-
fulness stage, LC neurons activate PeF neurons by a direct pathway
from LC nucleus to PeFLH area, as shown here. Moreover, electri-
cal stimulation of LC nucleus induced an increase in the neuronal
firing rate of PeF neurons by activation of catecholaminergic
receptors. The lateral hypothalamus receives a moderately dense
noradrenergic innervation (Baldo et al., 2003), most of which
arises from outside the LC nucleus (Yoshida et al., 2006). Our
study shows that neurons labeled after retrograde tracer injections
in LC nucleus were located in the ventral sector of PeFLH area.
Previous studies have described dense projections from PeFLH to
the LC in the rat (Luppi et al., 1995; España et al., 2005; Lee et al.,
2005b) and in the cat (Torterolo et al., 2013). The PeFLH neurons
projecting to the LC distribute within the hypothalamic region
containing the Orx cell group without any observed rostrocau-
dal or mediolateral topography, as occur in our experiments.
However, retrogradely-labeled lateral hypothalamic neurons after
LC nucleus tracer injections have been reported to locate also in
the dorsal half of the Orx-containing cell group (España et al.,
2005). This difference may be due to the tracer infusion volume
or the tracer uptake.
It is reasonable to believe that both effects, inhibition of REM
sleep generation and facilitation of arousal, could be performed
by the same PeF neuronal population. However, our anatomical
results indicate there are two different neuronal populations send-
ing separate projections to PnO and LC nuclei. In fact, injections
of retrograde tracers in PnO nucleus resulted in labeled neurons
in the PeF nucleus and in the medial sector of the PeFLH area,
while neurons labeled after retrograde tracer injections in LC
nucleus were located in the ventral sector of PeFLH area. Taken
together, these results suggest the existence of a neuronal network
between the lateral hypothalamus and brainstem structures that
may control the appropriate succession of the stages during sleep-
wakefulness cycle.Moreover, Orx neurons of the PeFLH area seem
to be an important organizer of the wakefulness and sleep stages
based on their anatomical projections and synaptic interactions
with different brainstem “sleep generators.” Thus, some sleep dis-
orders such as narcolepsy or insomnia may be due to alterations
of the Orx system.
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